Regonol
Pyridostigmine is a drug that has been approved by the U.S. Food and Drug Administration (FDA) to treat a condition called myasthenia gravis and to reverse the effects of muscle relaxants. In addition, pyridostigmine has been used in the military as a pretreatment for exposure to the chemical nerve agent Soman. It is also being studied as an investigational drug to treat HIV infection.